Back

Select your region

Arrange a consultation about stem cells

Learn more

FamiCord Suisse
FamiCord Group

Who we are?

FamiCord Suisse is part of the FamiCord Group and enables the storage of stem cells from umbilical cord blood, umbilical cord tissue, and placental tissue in Switzerland.

Our office is located in Zug, while storage takes place in Marly (Canton of Fribourg, Switzerland).

From consultation and registration during pregnancy to collection, transport, processing, and storage, all procedures are clearly defined and traceable.
Our activities are carried out in accordance with the requirements of Swissmedic and the Federal Office of Public Health.

The FamiCord Group is one of the largest stem cell banks in Europe and is among the leading providers worldwide in this field. It has many years of experience in the storage and release of samples for transplantation.
The Group is represented in numerous European countries through its own subsidiaries or partner companies. Expecting parents who wish to store umbilical cord blood, umbilical cord tissue, and placental tissue for their child can rely on this experience and infrastructure.

FamiCord Group facts and figures:

Icon

over 1 000 000 cord blood & other tissues units stored to date

Icon

7130 transplantations of mesenchymal stem cells from cord tissue

Icon

15 facilities in different parts of Europe: Poland, Hungary, Romania, Spain, Turkey, Switzerland, Portugal, Bulgaria, UK

Icon

Cooperation with over 1500 hospitals around Europe

Icon

235 cord blood transplantations

FamiCord_map_2025_07 (1)

Activity scale of the FamiCord Group

Through affiliate partners the Famicord Group offers its services also in Sweden, Ukraine, the United Kingdom, Serbia, Bosnia and Herzegovina, Montenegro and Albania

What makes us different?

Icon

no. 1 in Europe



Icon

the biggest and the most modern laboratory



Icon

>20 years of experience



Icon

certificates and accreditation



Icon

authorized to manufacture ATMPs

Icon

more security: 5 cryotubes of tissue per package

Icon

FamiCord Group is the most experienced in Europe
in use of stem cells

Decision for the future

When deciding on umbilical cord blood collection, it is imperative to choose a bank which will guarantee the optimal level of service quality. It provides our customers, who have entrusted their child’s precious blood samples, with the opportunity to forward the stored blood to the leading transplantation centers worldwide.

mother-holding-newborn-baby-sitting

Mission and vision

Our primary goal is to acquire and store stem cells from umbilical cord blood and umbilical cord. Our mission is to ensure that the stem cells obtained can be used to save your child’s life and health or, if there is sufficient genetic compatibility, other family members. The continuous implementation of this goal is confirmed by extensive, documented experience in transferring stem cells for transplantation. At every stage of our activity, we try to meet the highest technological and ethical standards to give our clients a sense of confidence that they have chosen a Partner whom they can trust for years. At Stemlab we believe that being a responsible company is right not only for the development of our business, but above all for parents who trusted us.

Thumbnail_FamiCord

Video: Famicord at a Glance

This video provides a concise overview of the FamiCord Group, its infrastructure, international collaboration, and its role in regenerative medicine. The FamiCord Group stores more than 1 million cord blood and tissue units across 15 facilities in Europe and operates a certified network of state-of-the-art laboratories as well as its own ATMP production centers.

The company collaborates with over 1,500 hospitals and has supported more than 7,600 stem cell transplantations. As Europe’s leading stem cell bank and ranked third worldwide, Famicord offers secure storage, international research partnerships, and a global transplant network.

With more than 20 years of experience, internationally recognized certifications, and advanced laboratory infrastructure, Famicord continues to drive progress in regenerative medicine and clinical research.

 

 

 

Famicord Group in Europe